Navigation Links
Volcano Sponsors First Study Designed to Determine if IVUS Can Identify Patients at Risk for Stent Thrombosis and to Demonstrate the Benefit of IVUS Guidance for Procedural Outcome
Date:10/22/2007

3,000 Patient Multi-center IVUS Sub-study Part of the Cardiovascular Research Foundation's ADAPT-DES Study to Quantify Causes and Cures of Drug

Eluting Stent Thrombosis

SAN DIEGO, Oct. 22 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC) [TCT Booth #2013 Level 2], a leading manufacturer of intravascular ultrasound (IVUS) and functional measurement (FM) technology, announced today its sponsorship of the first major study designed to examine the role of IVUS in ensuring accurate stent placement. The 3,000 patient IVUS sub-study is part of the Cardiovascular Research Foundation's (CRF) ADAPT-DES study (Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents), a prospective, multi-center registry of 11,000 (and up to 15,000) patients with coronary artery disease undergoing stent-assisted percutaneous coronary intervention (PCI) using drug-eluting stents (DES). The study's main objectives are to determine the frequency, timing and correlates (clinical, angiographic and IVUS) of DES thrombosis and the relationship of aspirin and/or clopidogrel hyporesponsiveness, and general platelet reactivity to early and late DES thrombosis.

"Although the benefits of IVUS have been anecdotally discussed by many interventional cardiologists and quantified in a number of published studies, the additive value of IVUS measures as independent predictors of stent thrombosis beyond the information present from clinical and angiographic variables has not been assessed in a prospective, multi-center registry," commented Gregg W. Stone, MD, Principal Investigator of ADAPT-DES and Chairman of the Cardiovascular Research Foundation. "The ADAPT-DES IVUS sub-study is expected to provide def
'/>"/>

SOURCE Volcano Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
3. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
4. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
5. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
6. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
7. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
8. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
9. First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
10. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
11. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013  The need ... cancer treatment continuum was highlighted prominently at the ... Urological Association (AUA), in San Diego.  According to ... intensity focused ultrasound (HIFU) technology, the need for ... and for urologists to consider minimally invasive ablative ...
(Date:5/23/2013)...  Every day, their baby stopped breathing, his collapsed bronchus ... April and Bryan Gionfriddo watched helplessly, just ... "Quite a few doctors said he had a good chance ... Gionfriddo , about her now 20-month-old son, Kaiba. "At ... would take it and run with it." They ...
(Date:5/23/2013)... May 23, 2013  Hologic, Inc. (Hologic or ... leading developer, manufacturer and supplier of premium diagnostics, ... emphasis on serving the healthcare needs of women, ... in a U.S. clinical practice comparing breast cancer ... with conventional 2D mammography alone showed a significant ...
Breaking Medicine Technology:Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 2Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 3Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 4Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 5Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 6Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 4First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 2First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 3First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 4
... , July 28 Intercept Pharmaceuticals, Inc., ... chronic fibrotic and metabolic diseases, today announced the signing ... the National Institute of Diabetes and Digestive and Kidney ... conduct a double blind, multi-center, study to evaluate the ...
... , WOONSOCKET, R.I. , July 27 CVS Caremark Corporation ... Wednesday, July 28, 2010 , at 9:30 a.m. (ET) with analysts ... the recently-announced strategic agreement with Aetna. , ... An audio webcast of the conference call will be broadcast simultaneously through the ...
Cached Medicine Technology:Intercept Pharmaceuticals to Collaborate With NIDDK on Study of Obeticholic Acid (INT-747) in Nonalcoholic Steatohepatitis (NASH) 2Intercept Pharmaceuticals to Collaborate With NIDDK on Study of Obeticholic Acid (INT-747) in Nonalcoholic Steatohepatitis (NASH) 3CVS Caremark Corporation to Hold Conference Call to Discuss: 2
(Date:5/24/2013)... On May 16, students, family members, and ... American University of Antigua (AUA) College of Medicine ... was the largest graduating class to date. The ceremony ... Vice President for Enrollment Management and Chief Operating Officer, ... Dean of Students and Professor and Chair – Physiology, ...
(Date:5/24/2013)... Reporter , , THURSDAY, May 23 (HealthDay News) -- Type ... with signs of serious complications seen just a few ... on the latest results, it seems like type 2 ... Chiang, senior vice president of medical affairs and community ... faster, and it appears to be at a more ...
(Date:5/24/2013)... (HealthDay News) -- Nearly three out of four ... and diarrhea, but these issues don,t significantly affect ... Researchers from Loyola University Medical Center in ... due to physiological and hormonal changes that occur ... pregnancy also can play a role. The study ...
(Date:5/24/2013)... UT (PRWEB) May 24, 2013 MonaVie announces ... America, as a new member of the Ethics Board of ... proud to have been elected to this council and will ... of the direct selling industry,” says Patrocinio. , The direct ... contributor to Brazil’s economy. The direct selling industry has, for ...
(Date:5/24/2013)... According to the new market research report “Micro Irrigation ... published by MarketsandMarkets, global micro irrigation system market expected ... year 2010 and is expected to reach $3,414.7 million ... 2011 to 2016. , Browse:, , ... , 370 pages and in-depth Table Of ...
Breaking Medicine News(10 mins):Health News:AUA Celebrates Seventh Annual Commencement Ceremony 2Health News:Type 2 Diabetes Progresses Faster in Kids, Study Finds 2Health News:Type 2 Diabetes Progresses Faster in Kids, Study Finds 3Health News:Bowel Issues Affect 3 Out of 4 Pregnant Women 2Health News:MonaVie Brazil Executive Elected to Ethics Board of ABEVD 2Health News:Micro Irrigation System Market to Reach $3414.7 Million by 2016 at a CAGR of 17.9% - New Report by MarketsandMarkets 2Health News:Micro Irrigation System Market to Reach $3414.7 Million by 2016 at a CAGR of 17.9% - New Report by MarketsandMarkets 3
... Oct. 8 Vyta Corp (OTC Bulletin Board:,VYTC) ... Nino Sorgente has,been formally engaged as an independent ... Vice President of Research and Development at,BIOAGRA, LLC, ... and Justin,Holdings, Inc. On September 15, 2008, Vyta ...
... Give an Hour, a,non-partisan, non-profit organization offering ... loved ones, announces a collaboration with,HelpPRO(R) -- a ... consumers nationwide to locate needed mental health professionals ... professionals, who join the Give,an Hour network offering ...
... cairns, funeral mounds, mummification, belief in life after death ... considered "odd" or even terrifying by another., The Greeks, ... of the ancient Issedonians chopping up their dead into ... barbeque, something entirely contrary to the Greeks, treatment of ...
... ALEXANDRIA, Va., Oct. 8 The National,Community Pharmacists ... one-term incumbent representing Georgia, for re-election to the,U.S. ... CEO of NCPA,issued the following statement:, "Senator ... and,America,s community pharmacies and the patients they serve. ...
... 8 The National,Community Pharmacists Association (NCPA) is ... Illinois, for re-election to the,U.S. Senate. Bruce Roberts, ... the following statement:, "Senator Richard Durbin is ... and the patients they serve. That is why ...
... Va., Oct. 8 The National,Community Pharmacists Association ... incumbent representing Kansas, for re-election to the,U.S. Senate. ... of NCPA,issued the following statement:, "Senator Pat ... America,s,community pharmacies and the patients they serve. That ...
Cached Medicine News:Health News:Vyta Corp Announces Engagement of Dr. Nino Sorgente as Independent Consultant 2Health News:HelpPRO and Give an Hour Join to Help Military Families Get Free Therapy Services 2Health News:Deathways open doors to unexpected cultural practices 2
The Chalam Mid Field lens can be used for air/gas exchange and has a bi-concave design to provide the widest field available in a direct image surgical lens. This lens was developed with K.V. Chalam,...
... 1.5x is specifically designed ... peeling in macular hole ... sheathotomy and macularepiretinal membrane ... and other situations warranting ...
The Flat is designed for routine vitrectomy, optic nerve neurotomy and induction of posterior vitreous detachments. It is also useful for macular hole surgery, epiretinal membranes and for removal of...
... MiniQuad ACS allows visualization of virtually ... with essentially coaxial positioning of the lens ... retinal detachment surgery, repairing giant retinal tears, ... for examining the peripheral retina in a ...
Medicine Products: